Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
– Sell
-13,088
Closed -$874K – 156
2019
Q2
$874K Hold
13,088
– – 0.12% 131
2019
Q1
$1.25M Buy
13,088
+5,000
+62% +$624K 0.18% 107
2018
Q4
$1M Hold
8,088
– – 0.17% 104
2018
Q3
$1.97M Sell
8,088
-3,000
-27% -$694K 0.23% 85
2018
Q2
$2.07M Sell
11,088
-4,500
-29% -$749K 0.23% 88
2018
Q1
$1.92M Hold
15,588
– – 0.23% 91
2017
Q4
$1.86M Sell
15,588
-2,500
-14% -$275K 0.24% 82
2017
Q3
$1.72M Sell
18,088
-2,000
-10% -$193K 0.27% 94
2017
Q2
$1.92M Sell
20,088
-8,000
-28% -$684K 0.33% 82
2017
Q1
$2.18M Sell
28,088
-5,000
-15% -$346K 0.45% 62
2016
Q4
$2.22M Sell
33,088
-4,400
-12% -$271K 0.52% 61
2016
Q3
$2.25M Hold
37,488
– – 0.51% 70
2016
Q2
$1.88M Buy
37,488
+9,000
+32% +$429K 0.46% 73
2016
Q1
$1.28M Sell
28,488
-1,200
-4% -$42.7K 0.31% 106
2015
Q4
$1.19M Buy
+29,688
New +$1.26M 0.28% 111

Other funds holding INGN

Formula Growth's INGN Position: Q3 2019 in Review

Formula Growth sold out of Inogen (INGN) in Q3 2019, closing a stake of 13,088 shares — an estimated $874K sold.

Formula Growth first reported a position in INGN in Q4 2015 and held it in 15 quarters. The position peaked at $2.25M in Q3 2016. 176 funds tracked by Wall St. Rank hold INGN as of Q3 2019.

  • Formula Growth reported no remaining Inogen position as of Q3 2019 after selling out during the quarter.
  • Formula Growth sold 13,088 Inogen shares in Q3 2019, an estimated $874K.
  • Formula Growth first reported a position in Inogen in Q4 2015 and held it in 15 quarters.
  • Formula Growth's Inogen position peaked at $2.25M in Q3 2016.
  • 176 funds tracked by Wall St. Rank held Inogen as of Q3 2019.

Based on Formula Growth's 13F filing for Q3 2019, filed 14 Nov 2019.